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Whether the recently identified innate lymphocyte
population coexpressing natural killer cell receptors
(NKRs) and the nuclear receptor RORgt is part of
the NK or lymphoid tissue inducer (LTi) cell lineage
remains unclear. By using adoptive transfer of
genetically tagged LTi-like cells, we demonstrate
that NKRRORgt+ innate lymphocytes but not NK
cells were direct progenitors to NKR+RORgt+ cells
in vivo. Genetic lineage tracing revealed that the
differentiation of LTi-like cells was characterized by
the stable upregulation of NKRs and a progressive
loss of RORgt expression. Whereas interleukin-7
(IL-7) and intestinal microbiota stabilized RORgt
expression within such NKR-LTi cells, IL-12 and
IL-15 accelerated RORgt loss. RORgt+ NKR-LTi cells
produced IL-22, whereas RORgt NKR-LTi cells
released IFN-g and were potent inducers of colitis.
Thus, the RORgt gradient in NKR-LTi cells serves
as a tunable rheostat for their functional program.
Our data also define a previously unappreciated
role of RORgtNKR-LTi cells for the onset or mainte-
nance of inflammatory bowel diseases.
INTRODUCTION
The evolutionarily ancient innate immune system is the first
barrier against infections and tumors. It is equipped with two736 Immunity 33, 736–751, November 24, 2010 ª2010 Elsevier Inc.principal hematopoietic cell lineages: myeloid and lymphoid. In
addition to natural killer (NK) cells, two additional innate lympho-
cyte subsets have been described: lymphoid tissue inducer (LTi)
cells and natural helper cells (also known as type 2 innate
lymphocytes or nuocytes) (Moro et al., 2010; Neill et al., 2010;
Price et al., 2010). Development of LTi cells, NK cells, and natural
helper cells depends on the transcription factor inhibitor of DNA
binding 2 (Id2), suggesting that the innate lymphocyte lineages
share a common transcriptional and developmental program
(Moro et al., 2010; Yokota et al., 1999). Specific transcription
factors and cytokines unique to LTi and NK cell fate decisions
have also been determined. Commitment to the LTi lineage
requires the orphan nuclear receptor RORgt and interleukin-7
(IL-7), whereas the NK cell fate is determined by the recently
identified transcription factor E4BP4 (NFIL3) and IL-15 (Gas-
coyne et al., 2009; Kennedy et al., 2000; Luther et al., 2003;Meier
et al., 2007; Sun et al., 2000).
NK cells are cytotoxic lymphocytes that express activating im-
munoreceptors (i.e., NKG2D; NCR1, also known as NKp46;
NKR-P1C, also known as NK1.1) allowing them to eliminate
infected, transformed, or stressed cells (Lanier, 2005). In addi-
tion, NK cells are potent producers of interferon-g (IFN-g).
During embryonic development, LTi cells are indispensable for
lymphorganogenesis (Mebius et al., 1997; Sun et al., 2000).
Lymphocytes phenotypically resembling LTi cells can also be
identified after birth but their role is not well defined. LTi-like cells
within the intestinal lamina propria of adult mice serve as inducer
cells of tertiary lymphoid organs such as cryptopatches and
intestinal lymphoid follicles, which are required for T cell-inde-
pendent IgA synthesis (Bouskra et al., 2008; Tsuji et al., 2008).
LTi cells are also an important innate source of IL-22 and IL-17
(Cupedo et al., 2009; Takatori et al., 2009) and may be involved
Immunity
NKR-LTi Cellsin repairing tissue damage after viral infections (Scandella et al.,
2008).
A population of IL-22-producing lymphocytes coexpressing
RORgt and activating NKRs (i.e., NKp46+RORgt+ cells) that
localized within the intestinal lamina propria was identified (Cella
et al., 2009; Cupedo et al., 2009; Hughes et al., 2009; Luci et al.,
2009; Sanos et al., 2009; Satoh-Takayama et al., 2008). In mice,
these cells are involved in safeguarding epithelial homeostasis
(Sanos et al., 2009) and in protecting against various forms of
experimental colitis (Satoh-Takayama et al., 2008; Zenewicz
et al., 2008). Similar to LTi cells, NKp46+RORgt+ cells depend
on RORgt for their differentiation and/or development and are
potent producers of IL-22. In contrast, conventional (c) NK cells
(i.e., NKp46+RORgt) are independent of RORgt and do not
produce IL-22 (Luci et al., 2009; Sanos et al., 2009; Satoh-
Takayama et al., 2008). It is unclear whether NKp46+RORgt+
cells are part of the NK cell or the LTi cell lineage or, alternatively,
constitute a third independent lineage of innate lymphocytes
(Cooper et al., 2009).
Chronic inflammatory disorders such as inflammatory bowel
diseases (Crohn’s disease, ulcerative colitis) are caused by
lymphocytes that are inappropriately activated and destroy
self-tissues. Recent data have assigned a disease-promoting
role to IL-23, a cytokine of the IL-12 family (Duerr et al., 2006;
Izcue et al., 2009). Such forms of autoimmunity have often
been perceived to be exclusively caused by lymphocytes of
the adaptive immune system, but recent evidence suggests
that IL-23-responsive innate lymphoid cells may be sufficient
to cause colitis in mice (Buonocore et al., 2010; Hue et al.,
2006; Uhlig et al., 2006). In mice lacking all lymphocytes of the
adaptive immune system (Rag2/), experimental colitis can
be triggered by CD40-mediated activation of myeloid cells or
by infection with Helicobacter hepaticus (Buonocore et al.,
2010; Hue et al., 2006; Uhlig et al., 2006). CD40-triggered colitis
is dependent on IL-23, IFN-g, and tumor necrosis factor (TNF)
(Uhlig et al., 2006) and cannot be triggered in animals genetically
lacking RORgt (Buonocore et al., 2010). However, the colito-
genic, IL-23-responsive innate lymphocyte subset remains
undefined (Diefenbach and Vonarbourg, 2010).
By using a combination of genetic lineage tracing and in vivo
transfer of genetically tagged cells, we report that RORgt+ innate
lymphoid cells (i.e., LTi-like cells) and not cNK cells are direct
progenitors to NKp46+RORgt+ lymphocytes in vivo. We now
refer to these as NKR-LTi cells. NKR-LTi cells progressively
lose RORgt expression, and the resulting gradient determines
a distinct phenotype and functional program. RORgt+ NKR-LTi
cells produced IL-22, whereas RORgt NKR-LTi cells released
large amounts of IFN-g. Interestingly, intestinal IFN-g-producing
RORgt NKR-LTi cells, but not cNK cells, were potent inducers
of experimental colitis. Thus, graded expression of RORgt
serves as a molecular rheostat to generate functional plasticity
within the NKR-LTi population.
RESULTS
NKp46–RORgt+ LTi-like Cells Are Progenitors
of NKp46+RORgt+ Cells
Consistent with the available data, three models can be
proposed for the differentiation of intestinal NKp46+RORgt+ cellsI(Figure S1A available online). One model (LTi lineage model) is
that NKp46+RORgt+ cells are derived from NKRRORgt+ LTi-
like cells that upregulate NKRs. Another model (NK lineage
model) proposes that NK cells, similar to IL-17-producing CD4
T cells (i.e., Th17 cells), upregulate RORgt expression as part
of a distinct differentiation program endowing these cells with
a particular functional profile (i.e., IL-22 production). NKp46+
RORgt+ cells could also represent a distinct third innate lympho-
cyte lineage independent of NK and LTi-like cells. It is currently
unknown which of these models is correct.
These models can be experimentally probed in cell transfer
experiments employing donor cells from mice with a reporter
gene (EGFP) knocked into the Rorc locus (encoding RORgt)
(Eberl et al., 2004). As previously reported, RORgt expression
serves as a faithful marker of intestinal LTi-like cells in adult
mice (Eberl and Littman, 2004). Other innate lymphocyte line-
ages (i.e., natural helper cells) do not express RORgt (Moro
et al., 2010). LTi cells andNKp46+RORgt+ cells were represented
in the lamina propria of the small intestine, colon, andmesenteric
LNs (Figure 1A; Eberl and Littman, 2004; Luci et al., 2009; Sanos
et al., 2009; Satoh-Takayama et al., 2008). We highly purified
(purity > 98%) NK cells (NKp46+RORgt) and genetically tagged
LTi-like cells (NKp46RORgt+) from the lamina propria of the
small intestine of Rorcgfp/+ mice (H-2b) (Figures S1B and S1C)
and transferred them into Rag2/Il2rg/ mice (H-2d) that lack
all lymphocytes including NK cells and LTi cells. Transferred
(H-2b) NK cells did not appreciably upregulate RORgt expres-
sion and remained NKp46+RORgt cells even 6 months after
transfer (Figure 1B and data not shown). In contrast, transferred
NKp46RORgt+ cells differentiated into NKp46+ cells but
a subpopulation remained negative for NKp46 even 6 months
after transfer (Figure 1B and data not shown). Upregulation of
NKp46 was already observed 2 weeks after transfer and the
fraction of NKp46+ LTi-derived cells further increased after
4 weeks (Figure 1B). Although virtually all of the donor-derived
cells found in the small intestine remained RORgt+, a consider-
able fraction of LTi-derived NKp46+ cells that homed to the
colonic lamina propria or the spleen turned off RORgt expres-
sion, demonstrating that the extent of RORgt downregulation
was dependent on the tissue environment (Figure 1B). Very
similar results were obtained when transferring colonic NK cells
or LTi cells (Figure S2A).
Our in vivo data were confirmed by an in vitro culture system.
Highly purified LTi-like cells (NKp46RORgt+) were cultured with
or without a stromal feeder cell layer for 7 days. A substantial
fraction of LTi cells readily upregulated NKp46 whereas NK cells
did not gain RORgt expression in vitro (Figure 1C). Although an
appreciable proportion of LTi-derived cells became RORgt
negative when the cells were cultured on an OP-9 stromal cell
layer, LTi-derived cells cultured in the absence of stromal cells
maintained RORgt expression (Figure 1C). This further corrobo-
rates the view that environmental cues influence maintenance or
loss of RORgt expression by LTi-derived NKp46+ cells.
Lymph Node LTi Cells Differentiate into NKR+ Cells
NKp46+RORgt+ cells were originally identified in the intestinal
immune system but it is unknown whether a similar cell type
exists in other organs. Although an appreciable population of
CD3CD19NKp46RORgt+ cells was detectable in spleenmmunity 33, 736–751, November 24, 2010 ª2010 Elsevier Inc. 737
Figure 1. NKp46+RORgt+ Cells Are Derived from NKp46–RORgt+ Precursors
(A) Flow cytometry analysis of NKp46 and RORgt (EGFP) expression by CD3CD19 lymphocytes from the indicated organs of Rorcgfp/+ mice. Numbers repre-
sent percent cells in quadrant.
(B) 2 3 104 of the indicated cell populations from the small intestine of Rorcgfp/+ mice (H-2b) were transferred into Rag2/Il2rg/ mice (H-2d). At the indicated
time points, donor-derived lymphocytes were analyzed for NKp46 and RORgt (EGFP) expression. Numbers represent percent cells in quadrant. n.d.: not done.
(C) Sorted cell populations from the intestinal lamina propria of Rorcgfp/+ mice were cultured with and without feeder cells for 7 days in vitro. Contour plots show
NKp46 and RORgt (EGFP) expression and were electronically gated on CD45+ cells. Numbers represent percent cells in quadrant.
Data are representative of three (C) or four (A, B) independent experiments.
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small proportion of RORgt-expressing NKp46+ lymphocytes
was present (Figure 1A). The NKp46RORgt+ subset repre-
sented adult-type LTi-like cells as they coexpressed various
LTi markers and displayed surface lymphotoxin a1b2 (sLTa1b2)
but did not express perforin or granzyme B (Figures S2B and
S2C). After transfer into Rag2/Il2rg/ mice, virtually all PLN-
derived LTi cells differentiated into NKp46+ cells, whereas NK
cells did not upregulate RORgt expression (Figure S2D). The
acquisition of NKp46 by PLN LTi-like cells was confirmed by
in vitro culture (Figures S2E and S2F). The differentiation of
PLN-derived LTi-like cells into NKp46+ cells that lost RORgt
occurred more rapidly and more completely compared to738 Immunity 33, 736–751, November 24, 2010 ª2010 Elsevier Inc.intestinal LTi cells (Figures 1B and 1C; Figures S2A versus
S2D–S2F). Conventional NK cells from PLN or spleen did not
upregulate RORgt (Figure S2F), even under culture conditions
that induce RORgt expression in CD4+ T cells (Figure S2G).
Thus, NKp46+RORgt+ cells differentiate from NKp46RORgt+
precursor cells (i.e., LTi-like cells) whereas cNK cells do not
acquire RORgt expression. Consequently, we will refer to these
cells as RORgt+ NKR-expressing LTi-like (NKR-LTi) cells.
Genetic Lineage Tracing Reveals Two Distinct
NKR-Expressing Lymphocyte Lineages
Based on our in vivo transfer data (Figure 1B; Figures S2A and
S2D), we considered that RORgt expression of NKp46+ cells
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mice. We used genetic lineage tracing (‘‘fate mapping’’) to visu-
alize in lymphoreplete mice all NKp46+ cells derived from
RORgt+ progenitors, including those that had lost RORgt. Mice
expressing Cre recombinase under the control of the Rorc locus
control elements (Rorc-CreTg) (Eberl and Littman, 2004) were
crossed with Rosa26-reporter mice (R26R-EYFP) (Srinivas
et al., 2001). The R26R-EYFP strain expresses a fluorescent
reporter under the control of the ubiquitously active Rosa26
promoter once the LoxP-flanked STOP cassette is excised (Fig-
ure S3A). In Rorc-CreTg;R26R-EYFP mice, all cells derived
from RORgt+ precursors are permanently and heritably marked
by the EYFP reporter (i.e., RORgtfm+), even if they subsequently
lose RORgt expression. RORgt expression by RORgtfm+ cells
can be analyzed through costaining with an RORgt-specific
antibody.
Analysis of innate lymphocytes from RORgt-fate map mice
revealed that a fraction of NKp46+ cells in all organs tested
(including the recently identified ‘‘thymic NK cells’’) was
RORgtfm, demonstrating that these cells did not express
RORgt at any time during their lineage development (Figure 2A;
Figure S3L). NKp46+RORgtfm cells displayed cell surface
markers consistent with NK cells (Figures S3B and S3C) and
expressed perforin and granzyme B, which are required for
cell-mediated cytotoxicity (Figure S3D). Taking into consider-
ation that under no conditions did NKp46+RORgt cells upregu-
late RORgt (Figures 1B and 1C; Figures S2A and S2D–S2G),
we conclude that NKp46+RORgtfm cells constitute a lympho-
cyte lineage developmentally distinct from RORgt-expressing
lymphoid cells. We refer to NKp46+RORgtfm cells as cNK cells
(Figure 2A).
RORgtfm+ cells can be further subdivided into an NKp46+ and
an NKp46 subset (Figure 2A). NKp46RORgtfm+ cells uniformly
expressed RORgt (Figure 2B) and sLTa1b2 (Figure S3E) but were
negative for perforin and granzyme B (Figure S3D) and thus
are identical to the NKp46RORgt+ LTi-like cell population.
This is also reflected by the absolute cell numbers of the
NKp46RORgt+ and the NKp46RORgtfm+ subsets that were
virtually identical (Figure S3F). Our transfer data demonstrated
that LTi-derived cells upregulate NKp46 and consecutively lost
RORgt (Figure 1B; Figures S2A and S2D). Thus, the entire
NKp46+ LTi cell-derived population should be contained within
the NKp46+RORgtfm+ subset. Costaining of RORgt in NKp46+
RORgtfm+ cells from various organs revealed the extent of RORgt
downregulation (Figures 2B and 2C) and exactly correlated with
our transfer experiments. Approximately 80% of NKp46+
RORgtfm+ cells of the small intestine were RORgt+, but <25%
of cells from colon, spleen, or PLNs expressed RORgt (Figures
2B and 2C). This was corroborated by analysis of absolute cell
numbers. In Rorcgfp/+ mice, only the RORgt+ NKR-LTi cells can
be visualized, which were lower in numbers compared to the
NKp46+RORgtfm+ subset from RORgt-fate map mice (Fig-
ure S3G). This difference was most visible in organs permissive
for RORgt loss (e.g., colon). Analysis of the ‘‘NK cell’’ population
revealed the corresponding result. In Rorcgfp/+ mice, the number
of NKp46+RORgt cells was always larger compared to the
NKp46+RORgtfm population because the NKp46+RORgt pop-
ulation contains cNK cells and RORgt NKR-LTi cells (Figures
2A–2C; Figure S3G).IWe aimed to identify markers of NKR-LTi cells that were influ-
enced by RORgt expression. In spleen and PLNs, CD4 was
expressed by the majority of LTi cells (Kim et al., 2008; Mebius
et al., 1997) and by a subpopulation of NKR-LTi cells whereas
cNK cells were negative (Figure 2D). CD4 NKR-LTi cells did
not express RORgt, but the CD4+ subset contained all RORgt+
NKR-LTi cells (Figure 2E). However, CD4 did not clearly discrim-
inate between the RORgt+ and the RORgt NKR-LTi subsets
in PLNs and only a small subpopulation of LTi cells and NKR-
LTi cells in the small intestine of adult mice expressed CD4
(Figure S3H). Interestingly, CD25 (IL-2Ra chain) and CCR6
(C-C chemokine receptor 6) expression distinguished between
RORgt+ and RORgt NKR-LTi cells (Figure 2F). RORgt+ NKR-
LTi cells also expressed high sLTa1b2 and CD127, which were
diminished (but not absent) in RORgt NKR-LTi cells (Figures
S3E and S3I). RORgt NKR-LTi cells expressed perforin and
granzyme B, indicating that they may mediate cell-mediated
cytotoxicity (Figure S3D). Thus, RORgt expression of NKR-LTi
cells profoundly influences gene expression of cell surface
markers and effector molecules.
RORgt+ NKR-LTi Cells Are Direct Progenitors
to RORgt– NKR-LTi Cells
As noted above, transfer of intestinal LTi cells into alymphoid
mice led to the generation of both RORgt+ and RORgt NKR-
LTi cells. To determine whether RORgt+ NKR-LTi cells are the
direct progenitors to RORgt NKR-LTi cells, we transferred
highly purified RORgt+ NKR-LTi cells (Figures S1B and S1C)
from the small intestine of RORgt-reporter mice (H-2b) into alym-
phoid mice (H-2d). Two weeks after transfer, most of the donor-
derived NKR-LTi cells in the small intestine retained RORgt
expression, whereas after 4 weeks, a substantial fraction had
downregulated RORgt (Figure 1B). In the environment of the
colon or spleen, the same donor cells almost entirely lost RORgt
expression (Figure 1B). Similarly, CD4+RORgt+ NKR-LTi cells
from PLNs differentiated into CD4+RORgt and further into
CD4RORgt NKR-LTi cells (Figure 2G). These data indicate
that the CD4+ subset of NKR-LTi cells contains RORgt+ NKR-
LTi cells and those that have recently lost RORgt. This is further
supported by data from a CD4-fate map in which most of the
CD4fm+ NKR-LTi cells did no longer express CD4, demonstrating
that CD4 NKR-LTi cells have a CD4+ progenitor (Figure 2H).
Thus, LTi cells differentiate in a two-step differentiation program
characterized by the stable upregulation of NKRs and the
progressive loss of RORgt expression: RORgt+ LTi cells /
RORgt+ NKR-LTi cells / RORgt NKR-LTi cells. Importantly,
LTi cell differentiation was restricted to NKR+ cells as shown
by the fact that LTi-like cells did not differentiate into any other
lymphocyte or myeloid cell population under homeostatic condi-
tions in vivo (Figures S3J–S3L).
Commensal Microflora and IL-7 Stabilize RORgt
Expression within NKR-LTi Cells
We and others had previously shown that the population
of RORgt+ NKR-LTi cells was diminished in germ-free mice
(Sanos et al., 2009; Satoh-Takayama et al., 2008). This could
reflect reduced differentiation of LTi-like cells into RORgt+
NKR-LTi cells or microbiota-dependent stabilization of RORgt
expression, slowing the progression to RORgt NKR-LTi cells.mmunity 33, 736–751, November 24, 2010 ª2010 Elsevier Inc. 739
Figure 2. Genetic Lineage Tracing Reveals Progressive Loss of RORgt in NKR-LTi Cells
(A) Flow cytometry analysis of NKp46 and RORgt-fate map (EYFP) in CD3CD19 lymphocytes from the indicated organs. Numbers represent percent cells in
each quadrant.
(B) Lymphocytes from the indicated organs of RORgt-fate map mice were stained with antibodies specific for CD3, CD19, NKp46, and RORgt or isotype control
antibody. Histograms are electronically gated on CD3CD19 cells and represent staining of the indicated cell populations with RORgt (gray) or isotype control
Ab (open). Numbers indicate percentages of RORgt+ cells.
(C) Percentage (±SEM, n = 7) of RORgt+ cells among all NKR-LTi cells in the indicated organs.
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did not lead to substantial differences in cNK, LTi, or NKR-LTi
cell populations both in relative and absolute numbers (Figure 3A
and data not shown). However, analysis of RORgt expression
within the NKR-LTi subset revealed that RORgt+ NKR-LTi cells
were significantly diminished in the absence of microbiota
(Figures 3A and 3B). Thus, the commensal microflora contributes
to the stabilization of RORgt within the NKR-LTi cell subset and
not to their differentiation from LTi-like progenitors.
An important question is whether the differentiation of RORgt+
into RORgt NKR-LTi cells requires proliferation. We labeled
highly purified intestinal RORgt+ NKR-LTi cells with a cell
proliferation dye and analyzed proliferation in the context of
RORgt expression after in vitro culture. Cells that downregulated
RORgt expression had proliferated, whereas RORgthi NKR-LTi
cells did not (Figure 3C). RORgt+ NKR-LTi cells cultured in IL-7
retained RORgt expression and proliferated less, whereas cells
cultured in IL-15 proliferated more and downregulated RORgt
expression (Figure 3C). Thus, loss of RORgt expression by
NKR-LTi cells required proliferation and IL-7 may be an impor-
tant factor for stabilizing RORgt.
IL-7 expression was reduced in the intestine of germ-free
mice, suggesting a mechanism for the destabilization of RORgt
expression of NKR-LTi cells (Figure 3D). We analyzed mice defi-
cient in IL-7, IL-7Ra, and TSLPR (thymic stromal lymphopoietin
receptor) for the presence of intestinal LTi-like cells, RORgt+
NKR-LTi cells, and NKp46+RORgt cells. In extension of previ-
ously published data, intestinal LTi-like and RORgt+ NKR-LTi
cells were virtually absent in Il7r/ mice that lack IL-7 and
TSLP signaling, whereas NK cell development was not impacted
(Figure 3E; Satoh-Takayama et al., 2010). In contrast, LTi-like
cells developed in Il7/ or Tslpr/ mice, albeit at reduced
numbers (Figures 3E and 3F). Thus, IL-7 and TSLP play redun-
dant roles for development and/or survival of intestinal LTi-like
cells. Despite equal representation of LTi-like cells in Il7/ and
Tslpr/mice, RORgt+ NKR-LTi cells were significantly reduced
in Il7/ (but not in Tslpr/) mice, whereas the numbers of
NKp46+RORgt cells (composed of cNK cells and RORgt
NKR-LTi cells) were substantially increased (Figures 3E–3G).
We considered that IL-7 stabilizes RORgt expression in NKR-
LTi cells. We transferred RORgt+ NKR-LTi cells from Rorcgfp/+
mice into mice treated with a blocking antibody to the IL-7R
or into mice overexpressing IL-7 (IL-7Tg mice). Although the
majority of donor-derived NKR-LTi cells retained RORgt expres-
sion in mice treated with control Ig, RORgt expression was
virtually lost in the absence of IL-7 signaling. In contrast, the
generation of RORgt NKR-LTi cells was diminished in mice(D) Splenocytes fromRORgt-fatemapmice were stained for CD3, CD19, NKp46, a
the proportion of CD4- and NKp46-expressing cells within the indicated cell pop
(E) Splenocytes from RORgt-fate map mice were stained for CD3, CD19, NKp46,
gated on CD3CD19 cells and depict expression of RORgt within CD4+ and CD
(F) Splenocytes fromRORgt-fate mapmice were stained for CD3, CD19, NKp46, C
cells and show coexpression of RORgt and CD25 (top) or CCR6 (bottom).
(G) 2 3 104 splenic CD4+RORgt+ NKR-LTi cells of Rorcgfp/+ mice (H-2b) were tra
(EGFP) expression by donor-derived cells (H-2b) was determined. Numbers repr
(H) Splenocytes from CD4-fate map mice were stained for CD3, CD19, NKp46, an
NKp46 and CD4 or CD4-fate map (EYFP). Histogram shows the percentage of N
Data are representative of ten (A), seven (C), four (B, D–G) or two (H) experiment
Ioverexpressing IL-7 (Figure 3H). These data were confirmed by
blocking IL-7R signaling in RORgt-fate map mice (Figure 3I; Fig-
ure S4A). Collectively, our data demonstrate that IL-7 but not
TSLP maintains the population of RORgt+ NKR-LTi cells.
No significant differences in absolute and relative numbers of
LTi-like cells, RORgt+ NKR-LTi cells, and NKp46+RORgt cells
were found in Il6/, Il1r/, and Il23p19/ mice (Figures
S4B–S4I). Interestingly, mice deficient for Il12a (encoding
IL-12p35) or Il12rb2, which is required for IL-12 but not IL-23
signaling, showed a significant increase in the fraction of intes-
tinal RORgt+ NKR-LTi cells (Figures S4F–S4I). This may imply
that IL-12 destabilizes RORgt expression in NKR-LTi cells.
Human ‘‘NK-22’’ but Not NK Cells Developmentally
Depend on IL7R Signaling
Human IL-22-producing CD56+NKp44+ cells isolated from
tonsils expressed IL22 and RORC, whereas conventional
CD56+NKp44 NK cells did not (Figure 4A; Cella et al., 2010).
A 4-stage differentiation program for human ‘‘NK cells’’ from
progenitor cells within secondary lymphoid organs was pro-
posed and it was found that ‘‘stage 3 NK cells’’ contained
IL-22-producing cells (Freud et al., 2006; Hughes et al., 2009).
Although stage 1, 2, and 4 NK cells from peripheral blood and
tonsils did not express IL22 or RORC, ‘‘stage 3 NK cells’’
expressed high RORC and IL22 (Figure 4B and data not shown).
Because cNK cells and their progenitors did not express RORgt
(Figure 2A), we reasoned that human IL-22-producing RORC+
CD56+ cells may represent human NKR-LTi cells. Mutations of
the IL7R gene in humans cause severe combined immunodefi-
ciency disease (SCID), and analysis of immune cells from these
patients revealed a substantial reduction of T cells, whereas
NK cells and B cells developed normally (Figure 4C; Lai et al.,
1997; Puel et al., 1998). We investigated the representation of
RORC+ IL-22-producing ‘‘stage 3 NK cells’’ in humans with
IL7R deficiency. ‘‘Stage 3 NK cells’’ were virtually absent in
patients with IL7R deficiency whereas stage 1, 2, and 4 were
represented normally (Figure 4D). Considering our mouse data
showing that cNK cells at no time express RORgt and that
they do not require IL-7 for their development, these data indi-
cate that human IL-22-producing lymphocytes are not part of
the cNK cell lineage but may be a subset of human NKR-LTi
cells.
RORgt Levels Assign Distinct Functional Programs
to NKR-LTi Cells
We found a previously unappreciated plasticity within RORgt+
innate lymphoid cells, allowing us to identify discrete LTind CD4. Density plots are electronically gated on CD3CD19 cells and depict
ulations.
CD4, and RORgt (gray) or with isotype control antibody (open). Histograms are
4 NKR-LTi cells. Numbers indicate percentages of RORgt+ cells.
D25, CCR6, and RORgt. Density plots are electronically gated on CD3CD19
nsferred into Rag2/Il2rg/ mice (H-2d). Two weeks later, CD4 and RORgt
esent percent cells in quadrants.
d CD4. Contour plots are gated on CD3CD19 cells and depict expression of
Kp46+CD4fm+ cells expressing CD4.
s.
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Figure 3. Commensal Microflora and IL-7 Stabilize RORgt Expression in NKR-LTi Cells
(A and B) Lymphocytes from the small intestine of conventional and antibiotic-treated RORgt-fate mapmice were stained with antibodies specific for CD3, CD19,
NKp46, NK1.1, and RORgt.
(A) Contour plots (left) are electronically gated on CD3CD19 cells and depict expression of RORgtfm (EYFP) and NKp46. Dot plots (right) are electronically gated
on NKR-LTi cells and represent staining for RORgt and NK1.1. Numbers indicate percentages.
(B) Percentage (±SEM, n = 3) of RORgt+ cells among NKR-LTi cells in conventional and antibiotic-treated RORgt-fate map mice.
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Figure 4. Human IL-22-Producing Cells Depend on IL-7 for Their Development
(A and B) Quantitative RT-PCR analysis of IL22 and RORC expression by the indicated populations from human tonsils (A) or peripheral blood (B). Stage 1,
CD34+CD117CD94; Stage 2, CD34+CD117+CD94; Stage 3, CD34CD117+CD94; Stage 4, CD34CD117CD94+.
(C and D) Mononuclear cells were stained with antibodies specific for the indicated markers and for CD3 and CD19. Dot plots (C) were electronically gated on
CD3CD19 cells. Contour plots (D) exclude all CD3+ and CD19+ cells and are electronically gated on CD34+ (stage 1 and stage 2) or CD34 cells (stage 3 and
stage 4). Numbers indicate percentage of cells within the adjacent gates. Data are representative of two independent experiments.
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NKR-LTi Cellscell-derived populations that develop along a decreasing
gradient of RORgt. IL-12 and IL-23 are related heterodimeric
cytokines acting on NK- and LTi-derived cells that signal through
related receptors (Oppmann et al., 2000). We investigated the(C) Highly purified RORgt+ NKR-LTi cells from the small intestine were labeled w
stained for NKp46 and RORgt. Numbers indicate percentages in each quadrant.
(D) Quantitative RT-PCR analysis (± SEM, n = 3) of Il7 expression in small intesti
(E) Absolute cell numbers (±SD, n = 5) of the indicated cell populations in the lam
(F and G) Lymphocytes of the small intestine were stained with antibodies speci
(F) Contour plots are electronically gated on CD3CD19 cells and numbers ind
(G) Percentage (±SD, n = 5) of NKp46+ cells among all RORgt+ cells.
(H) 23 104 highly purified RORgt+ NKR-LTi cells (CD45.1) from the small intestine
were treatedwith IL-7Ra antibodies or control Ig. Percentages (±SEM, n = 3) of RO
transfer.
(I) RORgt-fate map mice were treated with either IL-7Ra antibodies or control Ig.
mined after 6 days.
Data are representative of at least three independent experiments. n.s.: statistic
Iexpression of the IL-12 and IL-23 receptors (R) by cNK cells
and LTi-derived cells. The IL-12R and IL-23R complexes share
the IL-12 and IL-23R b1 chain that forms a heterodimer with
the IL-12-specific IL-12Rb2 chain or the IL-23-specific IL-23R.ith a cell proliferation dye and cultured in IL-7 or IL-15 for 6 days. Cells were
ne of control mice and germ-free mice.
ina propria of the small intestine.
fic for CD3, CD19, NKp46, and RORgt.
icate percentages within quadrants.
were transferred into groups of B6 (CD45.2) or IL-7Tg mice (CD45.2). B6 mice
Rgt+ cells among donor-derived cells (CD45.1+) were determined 2weeks after
Percentages (±SEM, n = 3) of RORgt+ cells among NKR-LTi cells were deter-
ally not significant; *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 5. RORgt Expression within NKR-LTi Cells Determines Distinct Functional Fates
(A) Splenocytes from RORgt-fate map mice were stained for CD3, CD19, NKp46, IL-12/23Rb1 (gray), or isotype control antibody (open). Histograms depict
electronic gating on the indicated cell populations after exclusion of CD3+ and CD19+ cells.
(B, C, G, H) Quantitative RT-PCR analysis of the expression of Il23r (B, G) and Il12rb2 (C, H) in sorted cell populations from spleen (B, C) or colon (G, H) of RORgt-
fate map mice.
(D and E) Cytokine production of highly purified cell populations from spleens of RORgt-fate map mice (D) or Rorcgfp/+ mice (E) stimulated for 24 hr with the indi-
cated cytokines. Contour plots depict staining with anti-IL-22 and anti-IFN-g. The numbers indicate the percentage of cells in each quadrant.
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Immunity
NKR-LTi CellsThe b1 chain was detected on the surface of all cNK cells, LTi
cells, and NKR-LTi cells from PLNs, spleen, and intestine
(Figure 5A and data not shown). Expression of Il23r correlated
with RORgt expression and was highest in LTi cells and CD4+
NKR-LTi cells whereas CD4 (i.e., RORgt) NKR-LTi cells
expressed very low and cNK cells had almost undetectable
amounts of Il23r (Figure 5B). In contrast, expression of Il12rb2
inversely correlated with RORgt expression (Figure 5C).
We stimulated highly purified lymphocytes from PLNs of
RORgt-fate mapmice with IL-12 or IL-23. Stimulation of LTi cells
and CD4+ NKR-LTi cells (containing all RORgt+ NKR-LTi cells)
with IL-23 led to IL-22 but not IFN-g production (Figure 5D).
CD4 (i.e., RORgt) NKR-LTi cells and cNK cells did not produce
IL-22 or IFN-g in response to IL-23, and LTi cells did not produce
either cytokine in response to IL-12, which is in agreement with
their very low Il23r or Il12rb2 expression, respectively (Figures
5B–5D). After IL-12 stimulation, highly purified cNK cells
produced IFN-g but not IL-22 (Figure 5D). Consistent with their
substantial expression of Il12rb2, CD4 (i.e., RORgt) NKR-LTi
cells also produced IFN-g in response to IL-12 stimulation but
had lost the potential to produce IL-22 (Figure 5D). CD4+
NKR-LTi cells that contain both RORgt+ and RORgt NKR-LTi
subsets (Figure 2E) showed a more complex cytokine
production pattern in response to IL-12. Although a substantial
population of CD4+ NKR-LTi cells produced IL-22, we noted
a similar fraction of IFN-g producers and even a highly repro-
ducible subset producing both cytokines (Figure 5D). CD4+
NKR-LTi cells are composed of RORgt+ NKR-LTi cells and
RORgt NKR-LTi cells that have very recently lost RORgt
expression (Figures 2E, 2G, and 2H). We reasoned that the cyto-
kine production profiles may be governed by the different
amounts of RORgt. Indeed, CD4+RORgt+ NKR-LTi cells
produced IL-22, whereas CD4+RORgt NKR-LTi cells produced
either IFN-g alone or both IFN-g and IL-22 (Figure 5E). Very
similar data were obtained after in vivo stimulation of NKR-LTi
cells. Splenic LTi cells and CD4+ NKR-LTi cells robustly
produced IL-22 (Figure 5F). Although LTi cells did not produce
IFN-g, a small fraction of IFN-g-producing cells was detected
within the population of CD4+ NKR-LTi cells that contains
RORgt NKR-LTi cells. As in the in vitro experiments, cNK cells
and CD4 (i.e., RORgt) NKR-LTi cells did not produce IL-22
but were instead IFN-g producers (Figure 5F). Our data demon-
strate that the gradual loss of RORgt expression within NKR-LTi
cells functions as a molecular rheostat for their responsiveness
to IL-12 family cytokines and for their cytokine expression
program.
RORgt– NKR-LTi Cells Are Potent Initiators
of Experimental Innate Colitis
RORgt+ NKR-LTi cells and LTi cells are constitutive IL-22
producers and promote epithelial homeostasis by regulating
expression of tissue-protective genes (e.g., Reg3 genes) (Sanos
et al., 2009). We attempted to assign function to the previously(F) Groups of RORgt-fate map mice were injected with LPS. 18 hr later, splenocy
CD4, IL-22, and IFN-g. Contour plots are electronically gated on the indicated c
percentage of cells in each quadrant.
(I) Highly purified lamina propria lymphocytes from the colon of RORgt-fate map
and RORgt. Numbers indicate the percentage of cells in each quadrant.
Iunrecognized population of RORgt NKR-LTi cells that is the
dominating subset of NKR-LTi cells in the colon (Figure 2C). In
contrast to RORgt NKR-LTi cells from PLN, colonic RORgt
NKR-LTi cells retained Il23r expression (Figures 5B, 5G, and
5H). Interestingly, colon RORgt NKR-LTi cells but not RORgt+
NKR-LTi, LTi, or cNK cells produced IFN-g in response to
IL-23 (Figure 5I and data not shown). IL-23-dependent IFN-g
production is required for the development of experimental
colitis in Rag2/ mice after systemic administration of CD40
antibodies but the colitogenic cell type is poorly defined (Buono-
core et al., 2010; Diefenbach and Vonarbourg, 2010; Uhlig et al.,
2006). Rag2/ mice injected with anti-CD40 developed exten-
sive colitis but Rag2/Il2rg/ mice that lack all lymphocytes
did not (Figures 6A and 6B). Colitis onset in Rag2/ mice
correlated with the presence of IFN-g-producing cells absent
in Rag2/Il2rg/ mice (Figure S5A). Thus, an innate IFN-g-
producing lymphocyte subset is required for pathogenesis.
CD40 injection into Rag2/mice led to the induction of IFN-g
production by NKp46+RORgt cells containing cNK cells and
RORgt NKR-LTi cells (Figure 6C). RORgt+ NKR-LTi cells and
LTi cells did not produce IFN-g but instead released IL-22
(Figure 6C). It should be noted that the fraction of IL-22- or
IL-17-producing cells was not augmented after CD40 stimulation
(Figure 6C; Figure S5B), which is in line with previous data indi-
cating that IL-17 is not involved in the pathogenesis of CD40
colitis (Buonocore et al., 2010). To determine whether RORgt
NKR-LTi cells or cNK cells are a cellular source of IFN-g in this
model, we injected anti-CD40 into Il15/ mice that lack all
cNK cells (Kennedy et al., 2000) but normally develop LTi-like
and NKR-LTi cells (Sanos et al., 2009). Anti-CD40 injection into
Il15/mice led to IFN-g production by NKp46+ cells, indicating
that RORgt NKR-LTi cells may be the IFN-g producers (Fig-
ure 6D). However, it remained possible that both cNK cells and
RORgt NKR-LTi cells contributed to the pool of IFN-g-
producing, colitis-promoting cells in normal mice. To definitively
identify the colitogenic IFN-g-producing cell type, we transferred
highly purified cells from RORgt-fate map mice into alymphoid
mice and injected CD40 antibodies 5 days later. During this
time, LTi cells and RORgt+ NKR-LTi cells did not appreciably
differentiate into RORgt cells (data not shown). Only RORgt
NKR-LTi cells produced IFN-g after CD40 injection whereas
cNK cells, RORgt+ NKR-LTi cells, and LTi cells did not (Fig-
ure 6E). Thus, RORgt NKR-LTi cells are the main source of
IFN-g during experimental colitis. The colitis-promoting role of
RORgt NKR-LTi cells was further confirmed in cell transfer
experiments. Only mice transferred with RORgt NKR-LTi cells
developed colitis comparable to Rag2/ mice (Figures 6F–6I).
Our data extend previous work reporting that the colitogenic
cells reside within a subset of Thy1+Sca1+ innate lymphoid cells
(Buonocore et al., 2010). The Thy1+Sca1+ population is heterog-
enous and contains RORgtfm and RORgtfm+ cells including
IFN-g-producing RORgt NKR-LTi cells (Figure S5C). Thus,
RORgt NKR-LTi cells but not cNK cells trigger innate colitis.te suspensions were stained with antibodies specific for CD3, CD19, NKp46,
ell populations after exclusion of all CD3+ and CD19+ cells. Numbers indicate
mice were cultured for 24 hr in IL-23. Contour plots depict expression of IFN-g
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Figure 6. RORgt– NKR-LTi Cells Induce CD40-Triggered Colitis
(A–D) Groups of Rag2/, Il15/, and Rag2/Il2rg/ mice were injected with control Ig or anti-CD40 and were analyzed 7 days later.
(A) Histological analysis of colon sections (H&E stain). Arrowhead points to a cluster of infiltrating leukocytes that can be found only in mice with colitis. Scale bars
represent 100 mm.
(B) Clinical colitis score (±SEM; n = 5).
(C and D) Lamina propria lymphocytes from colon were stained for CD45, NKp46, RORgt, IL-22, and IFN-g.
(C) Bar diagrams show percentages (±SEM; n = 5) of IFN-g- or IL-22-producing cells within the indicated lymphocyte populations.
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Immunity
NKR-LTi CellsFinally, we investigated colitis development in Rag2/ mice
depleted of cNK cells or NKR-LTi cells. Application of anti-
asialo-GM1 resulted in the depletion of most cNK cells, whereas
NKR-LTi cells and LTi cells were largely unaffected (Figure 7A).
Although almost all cNK cells were depleted, only a third of
cNK cells could be stained with the asialo-GM1 antiserum
(Figure 7A; Figure S6A). It is appreciated that the isolation proce-
dure from the intestinal lamina propria involving enzymatic
digests may interfere with the consecutive detection of antigens
(Sanos and Diefenbach, 2010). Intestinal RORgt NKR-LTi
cells and cNK cells expressed high levels of NK1.1 and were
depleted after injection of anti-NK1.1, whereas RORgt+ NKR-
LTi cells were NK1.1dim and (similar to NK1.1 LTi cells) were
not depleted (Figure 7A; Figure S6B). NK cells, NKR-LTi cells,
and LTi-like cells expressed high Thy1 (Figures S5C and S6C)
and anti-Thy1 injections led to the depletion of virtually all innate
lymphocyte populations (Figure 7B). Depletion of cNK cells by
anti-asialo-GM1 injection did not reduce the fraction of IFN-g-
or TNF-producing cells in the colon and did not ameliorate colitis
development (Figures 7B–7G). TNF was produced by myeloid
cells phenotypically resembling macrophages or monocyte-
derived cells (Figure S6D; Bogunovic et al., 2009; Varol et al.,
2009). In contrast, depletion of NK1.1+ cells, including RORgt
NKR-LTi cells, led to significant amelioration of the disease
(Figures 7B–7G). Not surprisingly, the depletion of all innate
lymphocytes by injection of Thy1 antibodies also prevented
colitis development (Figures 7B–7G). Collectively, these data
show that IFN-g-producing RORgt NKR-LTi cells are potent
inducers of experimental colitis.DISCUSSION
It is an important and unresolved question where to position the
recently identified population of IL-22-producing NKp46+
RORgt+ cells on hematopoietic lineage maps (Cooper et al.,
2009). Because Id2-deficient mice lack both LTi-like cells and
NK cells and because LTi-like cells could be differentiated into
NK-like cells in vitro, it was conceivable that LTi cells might be
progenitors to all NKR-expressing cells (Mebius et al., 1997;
Satoh-Takayama et al., 2010; Yokota et al., 1999). Lineage
tracing data via an RORgt-fate map excludes the development
of cNK cells and recently identified ‘‘thymic NK cells’’ (Vosshen-
rich et al., 2006) from RORgt+ precursors. Thus, cNK cells and
LTi-like cells are developmentally distinct and constitute sepa-
rate innate lymphocyte lineages.(D) Dot plots depict expression of IFN-g and IL-22 by NKR+RORgt cells. Numb
(E–I) 5 3 104 highly purified cells from the intestine of RORgt-fate map mice (H-2
(E) Five days after transfer, mice were injected with anti-CD40. Seven days after C
cate percentage of IFN-g+ cells.
(F–I) Two weeks after transfer, mice were injected with control Ig or anti-CD40 a
(F) Histological analysis of colon sections (H&E stain). Arrowheads point to cluster
represent 100 mm.
(G) Clinical colitis score (±SEM; n = 3).
(H) Absolute numbers (±SEM; n = 3) of leukocyte clusters (>120 mm) per colon.
(I) Weight as a percentage of the initial weight at day 0. Data represent the mea
group). Error bars were omitted for clarity.
n.s.: statistically not significant; *p < 0.05, **p < 0.01, ***p < 0.001.
IDo NKp46+RORgt+ cells then differentiate from NK cell or LTi
cell precursors or do they constitute a distinct third lineage of
innate lymphocytes? An intriguing hypothesis was that NK cells
upregulated RORgt under the influence of the intestinal micromi-
lieu and were instructed to a particular functional fate (i.e., IL-22
production). However, we failed to detect upregulation of RORgt
by cNK cells after in vivo transfer or under any in vitro conditions
tested, including those known to induce RORgt expression by
CD4 T cells. Thus, cNK cells are not the progenitors to NKp46+
RORgt+ cells.
We next considered that NKp46+RORgt+ cells may represent
LTi-like cells that upregulate NKRs. This view was supported by
our previous data showing that LTi-like cells and NKp46+RORgt+
cells share a similar developmental program (Sanos et al., 2009).
In addition, LTi cells can upregulate NKRs when cultured under
specific in vitro conditions (Cupedo et al., 2009; Mebius et al.,
1997). However, these conclusions relied on in vitro experiments
and on the definition of LTi cells by a combination of cell surface
markers, some of which (e.g., CD127, c-kit, CD25) have now
been shown to be also expressed by natural helper cells (Moro
et al., 2010). RORgt is the lineage-defining transcription factor
of LTi-like cells and is not expressed by any other of the recog-
nized innate lymphocyte lineages (Moro et al., 2010). Our lineage
tracing data also show that LTi-like cells permanently express
RORgt. Therefore, RORgt can be used to genetically mark LTi-
like cells (Eberl et al., 2004; Moro et al., 2010). By using a combi-
nation of genetic lineage tracing for RORgt and cell transfer
experiments of genetically tagged LTi cells, we demonstrated
that NKRRORgt+ cells are direct progenitors to NKR+RORgt+
cells but do not have the potential to develop into myeloid cells,
B cells, or T cells in vivo. These data firmly place LTi-like cells
within the lymphocyte lineage and demonstrate that the differen-
tiation potential of LTi cells in vivo is more limited than previously
appreciated. Although the marker profile of NKRRORgt+ (LTi-
like) cells was quite homogenous and the development of the
entire population depended on RORgt, subsets could be
discriminated on the basis of CD4 expression and different levels
of CD127 and c-kit. However, their shared developmental
program and data from CD4-fate mapping and in vivo transfer
studies support the view that these subsets represent differenti-
ation states of LTi-like cells. Future work will need to address
the developmental relationships of these subsets within the
NKRRORgt+ population of innate lymphoid cells.
Do IL-22+ NKR-LTi cells constitute a stable cell fate? We iden-
tified three stages of LTi cell differentiation that proceeded along
a decreasing gradient of RORgt expression. In the first transition,ers indicate the percentage of cells in each quadrant.
b) were transferred into Rag2/Il2rg/ mice (H-2d).
D40 injection, donor cells were analyzed for IFN-g production. Numbers indi-
nd analyzed 7 days later.
s of infiltrating leukocytes that can be found only in mice with colitis. Scale bars
n weight and are pooled from three independent experiments (n = 5 mice per
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Figure 7. Depletion of RORgt– NKR-LTi Cells Ameliorates Colitis
(A) Groups of RORgt-fate map were treated twice with the indicated antibodies. Two days after the last injection, intestinal lamina propria cells were stained with
NKp46, RORgt, CD3, and CD19. After exclusion of all CD3+ and CD19+ cells, the indicated populations were quantified. The data represent the percentage (±SD;
n = 5) of remaining cells compared to control Ig-treated groups.
(B–G) Groups ofRag2/mice were treated with the indicated antibodies and injected with control Ig or anti-CD40. Seven days later, lamina propria lymphocytes
from colon were stained for CD45, NKp46, RORgt, IL-22, IFN-g, or TNF.
(B) The dot plots represent the analysis of CD45+NKp46+RORgt cells that contain both cNK cells and RORgt NKR-LTi cells. Numbers represent percentage of
cells in the respective quadrants.
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Immunity
NKR-LTi CellsLTi-like cells (stage 1) acquired NKRs while maintaining RORgt
expression (stage 2). It is remarkable that a fraction of LTi-like
cells in the small intestine did not acquire NKRs even 6 months
after transfer. Perhaps, a subpopulation of NKRRORgt+ LTi-
like cells has self-renewing potential. While NKR expression
remained stable, NKR-LTi cells progressively lost RORgt and
this transition to the third stage may require proliferation. The
fraction of RORgt NKR-LTi cells varied from organ to organ,
suggesting that molecular cues from the microenvironment
may either stabilize RORgt expression or promote its loss.
Although the exact nature of these cues is poorly defined, we
now demonstrate that signals from the commensal microbiota
stabilize RORgt expression in NKR-LTi cells. This provides
a mechanistic explanation for our previous observation that the
numbers of RORgt+ NKR-LTi cells were decreased whereas
those of NKR+RORgt cells were increased in germ-free mice
(Sanos et al., 2009; Satoh-Takayama et al., 2008). The finding
that the fraction of RORgt NKR-LTi cells was less represented
in the colon than in the small intestine indicates that stabilization
of RORgt is not simply proportional to the number of bacteria.
Perhaps, specific microbiota present in the small intestine but
not in the colon promote RORgt expression. Furthermore, we
have uncovered an important role for IL-7, but not for the related
cytokine TSLP, in maintaining the pool of RORgt+ NKR-LTi cells.
IL-7 amounts were significantly decreased in germ-free mice,
providing a framework for the action of IL-7 in the maintainence
of RORgt+ NKR-LTi cells.
The level of RORgt expression determined the phenotype
and function of NKR-LTi cells. Whereas RORgt+ LTi-like cells
and RORgt+ NKR-LTi cells were potent producers of IL-22 and
expressed sLTa1b2, RORgt
 NKR-LTi cells instead expressed
IFN-g and upregulated expression of perforin and granzyme B.
Graded expression of RORgt served as a rheostat for the
responsiveness of NKR-LTi cells to the related cytokines IL-12
and IL-23. These results are reminiscent of a previous report
regarding the plasticity of Th17 cells that can downregulate
RORgt expression and become Th1-like IFN-g-producing cells
that promote autoimmune colitis (Lee et al., 2009).
Development and/or survival of intestinal and peripheral LTi-
like cells strictly required IL-7R signaling (Luther et al., 2003;
Meier et al., 2007; Satoh-Takayama et al., 2010; Schmutz
et al., 2009). Although LTi-like cells in PLN and spleen were
absent in Il7/ mice (Schmutz et al., 2009), intestinal LTi-like
cells were present. Our data demonstrate that TSLP and IL-7
play redundant roles for the differentiation of intestinal LTi-like
cells. This extends our previous data showing that overexpres-
sion of TSLP in Il7/ mice can rescue the differentiation of
PLN and splenic LTi cells (Chappaz and Finke, 2010). Because
LTi cells and NKR-LTi cells but not cNK cells strictly required
IL-7R signaling for their development, we investigated the devel-(C) The contour plots represent the analysis of all CD45+ cells. Numbers next to
(D) H&E staining of sections from the distal colon. Arrowheads point to inflamma
(E) Clinical colitis score (±SEM, n = 3).
(F) Mean numbers (±SEM, n = 3) of leukocyte clusters (>120 mm) per colon.
(G)Weight as a percentage of the initial weight at day 0. Data represent themeanw
Error bars were omitted for clarity.
n.s.: statistically not significant; *p < 0.05, **p < 0.01, ***p < 0.001.
Iopment of cNK cells and IL-22-producing NKR+ cells in patients
lacking IL-7R expression. Patients with IL7R deficiency had
a normal cNK cell compartment but selectively lacked IL-22-
producing NKR+ cells. These data demonstrate that human IL-
22-producing NKR+ cells share a common developmental
program with LTi-like cells and may not be associated with the
NK cell lineage.
Collectively, our data also enable us to more accurately name
these cells. Previous attempts (NK-22, NCR22) took into account
only their production of IL-22 and the expression of NKRs (Cella
et al., 2009; Satoh-Takayama et al., 2010). However, IL-22-
producing NKR-LTi cells are directly derived from LTi-like
progenitors and are just one discrete stage in a wider ranging
differentiation program. Thus, the designation NKR-LTi cells
more accurately reflects their lineage relationships and the
designation NK-22 or NCR22 may be appropriate only for the
subpopulation of IL-22-producing RORgt+ NKR-LTi cells.
Previously, RORgt NKR-LTi cells have gone unnoticed
because they were contained within the population of ‘‘NK cells’’
(i.e., NKp46+CD3) that in fact is a composite of two develop-
mentally and functionally distinct lymphocyte lineages: cNK cells
and LTi-derived NKR+ cells. We attempted to assign function to
RORgt NKR-LTi cells. In mice lacking all lymphocytes of the
adaptive immune system (Rag2/), autoimmune colitis can be
triggered by the application of CD40 antibodies, suggesting
that components of the innate immune system are sufficient
for the induction of colitis (Uhlig et al., 2006). Colitis development
required production of IFN-g or TNF but the colitogenic cell
type was unknown (Uhlig et al., 2006). A recent report demon-
strated that CD40 colitis could not be triggered in mice
genetically lacking RORgt (Buonocore et al., 2010). These mice
lack all LTi-derived cells but also do not have lymph nodes
or intestinal lymphoid clusters (Sun et al., 2000). It was not
explored whether colitis was diminished because of the absence
of LTi-derived cells or because of the lack of anatomical
sites for leukocyte interactions (Diefenbach and Vonarbourg,
2010). By using gain- and loss-of-function experiments, we
demonstrate that RORgt NKR-LTi cells are the colitogenic,
IFN-g-producing innate lymphocyte subset. Thus, RORgt
NKR-LTi cells are required and sufficient for the development
of innate colitis. Why are RORgt NKR-LTi cells such potent
inducers of colitis? An important pathological feature of colitis,
as well as of other chronic inflammatory processes, are de
novo generated proinflammatory leukocyte clusters (Aloisi and
Pujol-Borrell, 2006; Izcue et al., 2009). RORgt NKR-LTi cells
may still have lymphoid tissue-inducing potential as they express
sLTa1b2. Perhaps the composite qualities of proinflammatory
cytokine expression and induction of ectopic lymphoid tissues
make these cells uniquely positioned to induce and maintain
inflammation.the areas indicate percentage of TNF+ cells within gates.
tory foci. Scale bar represents 100 mm.
eight and is pooled from three independent experiments (n = 5mice per group).
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Immunity
NKR-LTi CellsEXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice and gene-targeted mice were purchased from Janvier, Charles
River Laboratories, Taconic Farms, or were provided by other laboratories.
A complete list of mouse strains used is available in the Supplemental
Experimental Procedures. All mice were used at 8–16 weeks of age. Antibiotic
treatment was performed as described (Rakoff-Nahoum et al., 2004). Experi-
ments were approved by and were in accordance with local animal care and
use committees.
Cell Isolation and Flow Cytometry
The isolation of lymphocytes from lamina propria and other organs as well as
staining of cell surface markers with fluorophore-conjugated antibodies were
performed as previously described (Sanos et al., 2009; Sanos and Diefenbach,
2010). The strategy for the analysis of innate lymphoid cells is depicted in
Figures S1E and S1F. Peripheral blood mononuclear cells (PBMCs) from
healthy donors were isolated after Pancoll density gradient centrifugation
(Biotech). Human tonsillar tissue was obtained from patients undergoing
tonsillectomy and blood samples were from healthy volunteers. Informed
written consent was obtained prior to sample acquisition from all donors
and all investigations have been conducted according to the principles
expressed in the Declaration of Helsinki. A list of antibodies used throughout
the study is available in the Supplemental Experimental Procedures.
In Vivo Differentiation
For the in vivo transfer experiments, lymphocytes were isolated from the indi-
cated organs and mice (H-2b), for LNs and spleen CD3+ and CD19+ cells were
removedwithmagnetic beads (Miltenyi) and cells were sorted twice on aMoFlo
sorter (Beckman Coulter). Cells used were >98% purity in the post-sort anal-
ysis (Figures S1B–S1D) and were injected intravenously into Rag2/Il2rg/
mice (H-2d). Donor-derived lymphocyte populations were analyzed at the indi-
cated time points. In some experiments, mice were injected every 3 days with
a blocking IL-7Ra (0.5 mg) antibody (clone A7R34).In Vitro Differentiation
For in vitro differentiation, 1000–5000 double sorted cells (purity > 98%) were
seeded into microtiter plates that were coated with irradiated OP-9 cells
(30 Gy) or left uncoated in medium supplemented with IL-15 (50 ng/ml), IL-7,
Flt3L, and/or SCF (20 ng/ml, each; all Peprotech). Cells were analyzed after
the indicated time points. In some experiments cells were labeled prior to
the culture with a cell proliferation dye according to themanufacturer’s instruc-
tions (eBioscience).In Vitro Stimulation and Intracellular Cytokine Staining
The indicated lymphocyte populations were stimulated overnight with
50 ng/ml IL-12 or 10 ng/ml IL-23 (Peprotech). Brefeldin A (Sigma) was added
for the last 4–6 hr of the stimulation period. Cytokine expression was analyzed
by intracellular staining.Experimental Colitis
CD40 colitis was induced as described (Uhlig et al., 2006). For transfer colitis,
5 3 104 cells of the indicated cell populations were transferred into
Rag2/Il2rg/mice and 2 weeks later, colitis was induced. Mice were sacri-
ficed 7 days after CD40 injection and colitis was evaluated according to clinical
and histological parameters (see Supplemental Experimental Procedures). In
some experiments, NKR+ cells were depleted by injections of 250 mg anti-
Thy1 (clones 30H12 and M5/49.4.1), 250 mg anti-NK1.1 (clone PK136), or
100 mg anti-asialo GM1 at days 1, +1, and +4.Real-Time PCR
Real-time PCR was performed as previously described (Sanos et al., 2009).
The amount of mRNA was normalized to that of the ‘‘housekeeping’’ gene
Hprt1 (encoding hypoxanthine guanine phosphoribosyl transferase). Primer
sequences are reported in the Supplemental Experimental Procedures.750 Immunity 33, 736–751, November 24, 2010 ª2010 Elsevier Inc.Statistical Analyses
ANOVA test was used to determine significance of the clinical colitis scores
and of leukocyte clusters. Student’s t test was used for all other data sets.
*p < 0.05, **p < 0.01, ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/
j.immuni.2010.10.017.
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